An open-label, single-arm, pilot study of Venetoclax in combination
with 5-day courses of Azacitidine in treatment-nai¨ve subjects with acute myelogenous leukemia who are =18 years of age and not eligible for standard induction therapy - VENAZA-5S PILOT TRIAL
An open-label, single-arm, pilot study of Venetoclax in combination
with 5-day courses of Azacitidine in treatment-nai¨ve subjects with acute myelogenous leukemia who are =18 years of age and not eligible for standard induction therapy - VENAZA-5S PILOT TRIAL
